March 1, 2021
Insulin Delivery Devices

Insulin Delivery Devices Market Size to Exceed US$ 22.5 Billion by 2026

Introduction

The global insulin delivery devices market is analyzed to grow at a CAGR of around 7.2% during the forecast period and projected to reach the market value over US$ 22.5 Bn in 2026. The study provides an extensive market evaluation and includes thorough ideas, facts, historical information, and statistically backed and industry-validated market data. It also includes predictions using appropriate hypotheses and methodologies. Moreover, the research report provides analysis and information according to categories such as type, applications, and geographic regions.

Download Free Sample Copy of Market Report@ https://www.acumenresearchandconsulting.com/request-sample/1636

Regional Outlook

Depending on geographic regions, global insulin delivery devices market is segmented into key regions: North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. As of 2018, the worldwide insulin delivery devices market dominated by North America in terms of market revenue. The Asia-Pacific region, on the other side, is expected to grow at highest CAGR during the forecast period. Different Asia-Pacific countries, mostly China, Japan and India, are important elements of regional development that thus affect the worldwide insulin delivery devices market.

Scope of the Report:

The report first uses historic data from different companies. The data collected is used to analyses the growth of industries in the past years. It includes data from the year 2015 to the year 2019. The forecast data provides the reader with an understating of the future of the market. The same data is used to predict the expectation of the companies and how they are expected to evolve in the coming years. The research provides historical as well as estimated data from the year 2019 to 2026. The details in the report give a brief overview of the market by examining its historical data, the current data, and forecast data to understand the growth of the market.

Competitive Landscape

The competition witnessed in the market is soaring. With rising demand for innovation, players are experimenting with various strategies to gain competitive edge and strengthen their foothold in the market. Several companies operating in the industry are looking at expanding their footprint across emerging nations to capitalize on the prevailing opportunities there. The gap in demand and supply of healthcare facilities in underdeveloped countries has resulted in the presence of unmet demand in these countries. These companies are looking at capitalizing on this to emerge at the fore of the global market.

Growth strategies adopted by the companies operating in the market are examined in detail. This is done to study how these strategies influence on this market. Furthermore, the bargaining power of suppliers and buyers. Furthermore, it reveals threat from new entrants and available substitute products.

Key Players

Profile of the key players in the global insulin delivery devices market will be provided, which include key financials, new developments and business strategies. These players contribute a major proportion towards market growth. Moreover, the industry’s present and future business perspective for latest innovations (including development possibilities and drivers, as well as difficulties and constraints for both emerged and emerging economies). This report also helps to analyse stakeholder market opportunities by identifying the high growth segments. On the other hand, few players of the insulin delivery devices market emphasize their regional presence in co-operation with retailers. The research also involves incisive competitive landscape and offers market players with important suggestions on effective imperatives and strategies. Competitive Landscape ‘ is included to provide a dashboard perspective for report viewers and access key differentiators among competitor companies.

The market share of the global insulin delivery devices market is dominated by companies like Novo Nordisk, Sanofi, Eli Lilly, Medtronic, Insulet, Ypsomed, Becton Dickinson, and others.

Key Segments

The report segments the market into various categories. The leading segments within each category are identified in the report. Furthermore, it calculates market share that these segments hold. Factors enabling growth in these segments are studied in detail. The report also reveals the factors that may restrain the market growth in these categories.

Market Segmentation

Market By Type

  • Insulin Syringe
  • Insulin Pens
  • Insulin Jet Injectors
  • Insulin Pumps
  • Insulin Needles
  • Insulin Inhalers

Market By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales
  • Diabetes Clinics & Centers

Market By End Use

  • Hospitals
  • Clinics
  • Ambulatory Care Centers
  • Homecare

Market By Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Get a Special Discount: sales@acumenresearchandconsulting.com | +1 407 915 4157

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Insulin Delivery Devices
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Insulin Delivery Devices Market By Type
1.2.2.1. Global Insulin Delivery Devices Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.2.2. Global Insulin Delivery Devices Market Revenue Share By Type in 2018
1.2.2.3. Insulin Syringe
1.2.2.4. Insulin Pens
1.2.2.5. Insulin Jet Injectors
1.2.2.6. Insulin Pumps
1.2.2.7. Insulin Needles
1.2.2.8. Insulin Inhalers
1.2.3. Insulin Delivery Devices Market By Distribution Channel
1.2.3.1. Global Insulin Delivery Devices Market Revenue and Growth Rate Comparison By Distribution Channel (2015-2026)
1.2.3.1.1. Hospital Pharmacies
1.2.3.1.2. Retail Pharmacies
1.2.3.1.3. Online Sales
1.2.3.1.4. Diabetes Clinics & Centers
1.2.4. Insulin Delivery Devices Market By End Use
1.2.4.1. Global Insulin Delivery Devices Market Revenue and Growth Rate Comparison By End Use (2015-2026)
1.2.4.2. Hospitals
1.2.4.3. Clinics
1.2.4.4. Ambulatory Care Centers
1.2.4.5. Homecare
1.2.5. Insulin Delivery Devices Market By Geography
1.2.5.1. Global Insulin Delivery Devices Market Revenue and Growth Rate Comparison By Geography (2015-2026)
1.2.5.2. North America Insulin Delivery Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Insulin Delivery Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Insulin Delivery Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Insulin Delivery Devices Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Insulin Delivery Devices Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Insulin Delivery Devices Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Insulin Delivery Devices Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Insulin Delivery Devices Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Insulin Delivery Devices Major Manufacturers in 2018

CHAPTER 4. INSULIN DELIVERY DEVICES MARKET BY TYPE
4.1. Global Insulin Delivery Devices Revenue By Type
4.2. Insulin Syringe
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Insulin Pens
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Insulin Jet Injectors
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.5. Insulin Pumps
4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.6. Insulin Needles
4.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.7. Insulin Needles
4.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.8. Insulin Inhalers
4.8.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.8.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 5. INSULIN DELIVERY DEVICES MARKET BY DISTRIBUTION CHANNEL
5.1. Global Insulin Delivery Devices Revenue By Distribution Channel
5.2. Hospital Pharmacies
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Retail Pharmacies
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.4. Online Sales
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.5. Diabetes Clinics & Centers
5.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 6. INSULIN DELIVERY DEVICES MARKET BY END USE
6.1. Global Insulin Delivery Devices Revenue By End Use
6.2. Hospitals
6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.3. Clinics
6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.4. Ambulatory Care Centers
6.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.5. Homecare
6.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 7. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET BY COUNTRY
7.1. North America Insulin Delivery Devices Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. North America Insulin Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Insulin Delivery Devices Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
7.3.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
7.4.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)

CHAPTER 8. EUROPE INSULIN DELIVERY DEVICES MARKET BY COUNTRY
8.1. Europe Insulin Delivery Devices Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Europe Insulin Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
8.3.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
8.4.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
8.5.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.6.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
8.6.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
8.7.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
8.7.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET BY COUNTRY
9.1. Asia-Pacific Insulin Delivery Devices Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Asia-Pacific Insulin Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
9.3.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
9.4.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
9.5.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
9.6.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
9.6.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
9.7.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
9.7.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
9.8.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
9.8.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)

CHAPTER 10. LATIN AMERICA INSULIN DELIVERY DEVICES MARKET BY COUNTRY
10.1. Latin America Insulin Delivery Devices Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Latin America Insulin Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
10.3.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
10.4.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
10.5.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET BY COUNTRY
11.1. Middle East & AFRICA Insulin Delivery Devices Market Revenue and Growth Rate, 2015 – 2026 ($Million)
11.2. Middle East & AFRICA Insulin Delivery Devices Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. GCC
11.3.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
11.3.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
11.3.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
11.4. South Africa
11.4.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
11.4.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
11.4.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
11.5. Rest of Middle East & AFRICA
11.5.1. Market Revenue and Forecast By Type, 2015 – 2026 ($Million)
11.5.2. Market Revenue and Forecast By Distribution Channel, 2015 – 2026 ($Million)
11.5.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. Novo Nordisk
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Type Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Sanofi
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Type Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Eli Lilly
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Type Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Medtronic
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Type Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Insulet
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Type Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Ypsomed
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Type Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Becton Dickinson
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Type Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Others
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Type Portfolio
12.8.5. Key Developments
12.8.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

The report is readily available and can be dispatched immediately after payment confirmation.

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1636

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact-based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Saurabh

Saurabh is an SEO Analyst professional, working on a large marketing and sales platform that helps firms attract visitors and close customers. Proficient in monitoring and evaluating search results and search performance across the major search channels. With his strong analytical skills. Saurabh covers healthcare, technological, chemical, lifestyle and trendy news from all over the world.

View all posts by Saurabh →

Leave a Reply

Your email address will not be published. Required fields are marked *